Arcellx to Advance the Conversation on Its Platform and the Importance of Early CAR T Access for Patients with Multiple Myeloma During the 2026 Tandem Meetings 21 January
Arcellx Announces New Positive Data for Its iMMagine-1 Study in Patients with Relapsed and/or Refractory Multiple Myeloma 06 December 2025
Arcellx to Host Investor Relations Event During the 67th ASH Annual Meeting and Exposition 18 November 2025
